Sprains

• FDA approval · 2024-11-21
  FDA Approved: FLECTOR — Supplemental Application (IBSA Pharma Inc.)

  FDA approved a supplemental application for FLECTOR (diclofenac epolamine) submitted by IBSA Pharma Inc.

• CLINICAL_TRIALS trial_result · 2024-03-25
  Clinical Trial Update: Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department [Phase 3]

  A Phase 3 trial evaluating the efficacy of a lidocaine patch for acute musculoskeletal pain in emergency department settings has completed w…

• CLINICAL_TRIALS trial_result · 2023-09-28
  Clinical Trial Update: Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain [Phase 2]

  Phase 2 trial assessing the efficacy and safety of an esflurbiprofen hydrogel patch for local acute pain due to soft tissue injuries and con…

• FDA approval · 2021-04-28
  FDA Approved: FLECTOR — Supplemental Application (IBSA Pharma Inc.)

  FDA approved a supplemental application for FLECTOR (diclofenac epolamine) submitted by IBSA Pharma Inc.

• CLINICAL_TRIALS trial_result · 2011-06-15
  Clinical Trial Update: Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel [Phase 3]

  Phase 3 study comparing ibuprofen 50 mg/g gel with Profenid 25 mg/g gel to assess efficacy and safety in musculoskeletal conditions includin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2010-04-16
  Clinical Trial Update: To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury. [Phase 3]

  Phase 3 clinical trial comparing Aliviador to Gelol in patients with contusions, sprains, trauma, and muscle injuries; trial status is unkno…

• FDA approval · 2009-09-03
  FDA Approved: FLECTOR — Supplemental Application (IBSA Pharma Inc.)

  FDA approved a supplemental application for FLECTOR (diclofenac epolamine) from IBSA Pharma Inc. The action pertains to modifications to the…